X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse PLETHICO PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
PLETHICO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs395353-   
Low Rs31255-   
Sales per share (Unadj.) Rs604.4105.0-  
Earnings per share (Unadj.) Rs32.5-26.5-  
Cash flow per share (Unadj.) Rs51.3-21.9-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.682.4-  
Shares outstanding (eoy) m34.08168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.42.9 12.2%   
Avg P/E ratio x6.6-11.5 -57.1%  
P/CF ratio (eoy) x4.2-13.9 -30.0%  
Price / Book Value ratio x0.53.7 12.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,26251,290 14.2%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,5963,219 49.6%   
Avg. sales/employee Rs ThNM4,129.2-  
Avg. wages/employee Rs ThNM749.8-  
Avg. net profit/employee Rs ThNM-1,040.5-  
INCOME DATA
Net Sales Rs m20,59817,727 116.2%  
Other income Rs m386124 311.2%   
Total revenues Rs m20,98417,851 117.6%   
Gross profit Rs m2,818-3,072 -91.7%  
Depreciation Rs m642765 84.0%   
Interest Rs m1,593480 331.8%   
Profit before tax Rs m969-4,193 -23.1%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138262 -52.8%   
Profit after tax Rs m1,107-4,467 -24.8%  
Gross profit margin %13.7-17.3 -78.9%  
Effective tax rate %-14.3-6.2 228.7%   
Net profit margin %5.4-25.2 -21.3%  
BALANCE SHEET DATA
Current assets Rs m18,87712,983 145.4%   
Current liabilities Rs m11,8967,305 162.9%   
Net working cap to sales %33.932.0 105.8%  
Current ratio x1.61.8 89.3%  
Inventory Days Days36111 32.4%  
Debtors Days Days198124 159.6%  
Net fixed assets Rs m9,8617,568 130.3%   
Share capital Rs m34182 414.0%   
"Free" reserves Rs m12,3310-   
Net worth Rs m16,13913,914 116.0%   
Long term debt Rs m4,7064,889 96.2%   
Total assets Rs m33,14626,284 126.1%  
Interest coverage x1.6-7.7 -20.8%   
Debt to equity ratio x0.30.4 83.0%  
Sales to assets ratio x0.60.7 92.1%   
Return on assets %8.1-15.2 -53.7%  
Return on equity %6.9-32.1 -21.4%  
Return on capital %12.3-19.8 -62.0%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,4371,513 161.1%  
From Investments Rs m-6,265-465 1,348.4%  
From Financial Activity Rs m2,4904,438 56.1%  
Net Cashflow Rs m-1,3375,486 -24.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.87 Rs / ZAR

Compare PLETHICO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PLETHICO PHARMA With: GLENMARK PHARMA  CIPLA  AJANTA PHARMA  MERCK LTD  ABBOTT INDIA  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS